Johnson & Johnson announces $1B Firefly Bio acquisition to expand oncology pipeline
New Brunswick-based Johnson & Johnson has entered into a definitive agreement to acquire Firefly Bio, Inc., a biotechnology company advancing its proprietary Firelink degrader...